Federated Hermes’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,534
Closed -$49.1K 2098
2024
Q4
$49.1K Sell
8,534
-79,594
-90% -$458K ﹤0.01% 1670
2024
Q3
$913K Sell
88,128
-42
-0% -$435 ﹤0.01% 1151
2024
Q2
$1.14M Sell
88,170
-2
-0% -$26 ﹤0.01% 1063
2024
Q1
$1.54M Sell
88,172
-45,017
-34% -$786K ﹤0.01% 1010
2023
Q4
$1.25M Buy
+133,189
New +$1.25M ﹤0.01% 1063
2022
Q1
Sell
-7
Closed -$1K 2228
2021
Q4
$1K Hold
7
﹤0.01% 2110
2021
Q3
$1K Sell
7
-108
-94% -$15.4K ﹤0.01% 2134
2021
Q2
$5K Sell
115
-27,376
-100% -$1.19M ﹤0.01% 2029
2021
Q1
$1.36M Sell
27,491
-38,513
-58% -$1.9M ﹤0.01% 1253
2020
Q4
$2.78M Sell
66,004
-11,545
-15% -$486K 0.01% 961
2020
Q3
$3.55M Buy
77,549
+445
+0.6% +$20.4K 0.01% 810
2020
Q2
$3.87M Buy
77,104
+51,733
+204% +$2.6M 0.01% 775
2020
Q1
$1.31M Buy
25,371
+25,229
+17,767% +$1.3M ﹤0.01% 1032
2019
Q4
$9K Sell
142
-8,131
-98% -$515K ﹤0.01% 1910
2019
Q3
$497K Buy
8,273
+37
+0.4% +$2.22K ﹤0.01% 1453
2019
Q2
$695K Sell
8,236
-2,610
-24% -$220K ﹤0.01% 1378
2019
Q1
$1.04M Sell
10,846
-31,761
-75% -$3.03M ﹤0.01% 1298
2018
Q4
$3.02M Sell
42,607
-13,725
-24% -$972K 0.01% 888
2018
Q3
$4.81M Sell
56,332
-11,220
-17% -$959K 0.01% 818
2018
Q2
$7.83M Buy
67,552
+67,501
+132,355% +$7.82M 0.02% 547
2018
Q1
$4K Buy
+51
New +$4K ﹤0.01% 1994
2017
Q2
Sell
-250
Closed -$8K 2135
2017
Q1
$8K Sell
250
-210
-46% -$6.72K ﹤0.01% 1846
2016
Q4
$15K Buy
+460
New +$15K ﹤0.01% 1780
2015
Q2
Sell
-12,591
Closed -$386K 1982
2015
Q1
$386K Sell
12,591
-11,521
-48% -$353K ﹤0.01% 1426
2014
Q4
$1.23M Buy
24,112
+683
+3% +$34.7K ﹤0.01% 1112
2014
Q3
$927K Buy
23,429
+23,251
+13,062% +$920K ﹤0.01% 1215
2014
Q2
$8K Buy
+178
New +$8K ﹤0.01% 1756